当前位置:
X-MOL 学术
›
J. Adv. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Risk classification for non-cancer death in middle-aged cancer patients
Journal of Advanced Research ( IF 11.4 ) Pub Date : 2024-12-25 , DOI: 10.1016/j.jare.2024.12.039 Tianwang Guan, Yanting Jiang, Peinan Tu, Baokui Ye, Liangjia Zeng, Zehao Luo, Kaiyi Chi, Haowen Liang, Yuting Yang, Jinqi Huang, Binghua Zhang, Rundong Tai, Jujian Ye, Zhilin Deng, Yushen Ke, Huiwan Chen, Zhiling Zhang, Zhigang Liu, Caiwen Ou
中文翻译:
中年癌症患者非癌性死亡风险分级
非癌症事件是癌症患者竞争性死亡率的重要原因。然而,中年癌症患者非癌症死亡的风险和风险分类尚不清楚。全面分析中年患者 24 种不同癌症的非癌症死亡风险。
采用标化死亡率 (SMR) 、绝对超额风险 (AER) 、死亡比例、年龄调整死亡率 (AAMR) 和竞争模型评估中年癌症患者非癌死亡风险。根据非癌症死亡的竞争风险和非癌症死亡的风险(风险比),为 24 种癌症类型开发了非癌症死亡风险分类。
共确定了 24 种癌症类型的 1,082,030 名中年癌症患者。与一般中年人群相比,中年癌症患者的非癌症死亡风险升高 (SMR = 3.37,95% CI 3.35-3.39,AER = 99.18)。在 15 种癌症类型中,与原发性癌症相比,非癌症原因的累积死亡率更高。非癌症原因的 AAMR 从 2.3 年的 1975% 下降到 1.4 年的 2017%。开发了风险分类,将不同的癌症分为 6 个风险类别。
中年癌症患者的非癌症死亡风险升高,并且因癌症类型而异。开发了一种新的风险分类系统来估计不同癌症中非癌症死亡的风险,并将 24 种癌症类型分为 6 个不同的类别。这些结果强调了中年癌症患者非癌症死亡风险分层管理的必要性。
更新日期:2024-12-26
Journal of Advanced Research ( IF 11.4 ) Pub Date : 2024-12-25 , DOI: 10.1016/j.jare.2024.12.039 Tianwang Guan, Yanting Jiang, Peinan Tu, Baokui Ye, Liangjia Zeng, Zehao Luo, Kaiyi Chi, Haowen Liang, Yuting Yang, Jinqi Huang, Binghua Zhang, Rundong Tai, Jujian Ye, Zhilin Deng, Yushen Ke, Huiwan Chen, Zhiling Zhang, Zhigang Liu, Caiwen Ou
Introduction
Non-cancer events are important causes of competing mortality among cancer patients. However, the risk of non-cancer death and risk classification in middle-aged cancer patients is not clear. To comprehensively analyze the risk of non-cancer deaths in 24 different cancers among middle-aged patients.Methods
Standardized mortality rate (SMR), absolute excess risk (AER), proportion of deaths, age-adjusted mortality rate (AAMR), and the competing model were used to assess the risk of non-cancer death in middle-aged cancer patients. A non-cancer death risk classification was developed for the 24 cancer types based on the competing risk of non-cancer death and the risk of non-cancer death (hazard ratio).Results
A total of 1,082,030 middle-aged cancer patients of 24 cancer types was identified. The risk of non-cancer death was elevated in middle-aged cancer patients compared to the general middle-aged population (SMR = 3.37, 95 % CI 3.35–3.39, AER = 99.18). The cumulative mortality was higher for non-cancer causes compared to primary cancer in 15 cancer types. The AAMR for non-cancer causes declined from 2.3 % in 1975 to 1.4 % in 2017. A risk classification was developed to classify different cancers into 6 risk categories.Conclusion
The risk of non-cancer death was elevated in middle-aged cancer patients and varied for different cancer types. A new risk classification system was developed to estimate the risk of non-cancer deaths in different cancers, and the 24 cancer types were classified into 6 distinct categories. These results highlight the necessity for risk stratification management for non-cancer death in middle-aged cancer patients.中文翻译:
中年癌症患者非癌性死亡风险分级
介绍
非癌症事件是癌症患者竞争性死亡率的重要原因。然而,中年癌症患者非癌症死亡的风险和风险分类尚不清楚。全面分析中年患者 24 种不同癌症的非癌症死亡风险。
方法
采用标化死亡率 (SMR) 、绝对超额风险 (AER) 、死亡比例、年龄调整死亡率 (AAMR) 和竞争模型评估中年癌症患者非癌死亡风险。根据非癌症死亡的竞争风险和非癌症死亡的风险(风险比),为 24 种癌症类型开发了非癌症死亡风险分类。
结果
共确定了 24 种癌症类型的 1,082,030 名中年癌症患者。与一般中年人群相比,中年癌症患者的非癌症死亡风险升高 (SMR = 3.37,95% CI 3.35-3.39,AER = 99.18)。在 15 种癌症类型中,与原发性癌症相比,非癌症原因的累积死亡率更高。非癌症原因的 AAMR 从 2.3 年的 1975% 下降到 1.4 年的 2017%。开发了风险分类,将不同的癌症分为 6 个风险类别。
结论
中年癌症患者的非癌症死亡风险升高,并且因癌症类型而异。开发了一种新的风险分类系统来估计不同癌症中非癌症死亡的风险,并将 24 种癌症类型分为 6 个不同的类别。这些结果强调了中年癌症患者非癌症死亡风险分层管理的必要性。